Stocks and Investing
Stocks and Investing
Fri, January 11, 2013
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:34 AM ] - United States, Market Wire
[ 06:00 AM ] - United States, Market Wire
[ 04:49 AM ] - United States, WOPRAI
[ 04:49 AM ] - United States, WOPRAI
[ 04:48 AM ] - United States, WOPRAI
[ 04:48 AM ] - United States, WOPRAI
[ 04:47 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 03:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kevin Fischbeck Upgraded (THC) to Strong Buy and Increased Target to $42 on, Jan 11th, 2013
Kevin Fischbeck of B of A Securities, Upgraded "Tenet Healthcare Corporation" (THC) to Strong Buy and Increased Target from $32 to $42 on, Jan 11th, 2013.
Kevin has made no other calls on THC in the last 4 months.
There are 2 other peers that have a rating on THC. Out of the 2 peers that are also analyzing THC, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jamie Perse of "Goldman Sachs" Maintained at Hold with Increased Target to $25 on, Thursday, October 11th, 2012
This is the rating of the analyst that currently disagrees with Kevin
- Gary Taylor of "JP Morgan" Initiated at Buy and Held Target at $41 on, Tuesday, December 18th, 2012
Contributing Sources